Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Appointment of Director

20 Apr 2018 14:00

RNS Number : 6578L
Highbridge Multi-Strategy Fd Ltd £
20 April 2018
 

HIGHBRIDGE MULTI-STRATEGY FUND LIMITED (the "Company")

 

APPOINTMENT OF DIRECTOR

 

Pursuant to the succession planning process described in the Chairman's statement in the Company's most recent Annual Financial Report, the Company is pleased to announce the appointment of Mr Paul Le Page as a non-executive director of the Company with effect from 1 May, 2018.

 

Mr Paul Le Page is a director of FRM Investment Management (Guernsey) Limited, Man Fund Management Guernsey Limited and Man Group Japan Limited which are subsidiaries of Man Group plc. He is responsible for managing hedge fund portfolios, and is a director of a number of group funds.

 

Mr Paul Le Page is currently Audit Committee Chairman for UK Mortgages Limited and Bluefield Solar Income Fund Limited. He was formerly a Director of, and Audit Committee Chairman for, Cazenove Absolute Equity Limited and Thames River Multi Hedge PCC Limited.

 

Mr Paul Le Page holds, or has held within the five years prior to the date of this announcement, the following directorships and partnerships of publicly quoted companies:

 

Bluefield Solar Income Fund Limited (current directorship)

UK Mortgages Limited (current directorship)

Thames River Multi Hedge PCC Limited (past directorship)

 

Mr Vic Holmes, Chairman of the Company said: "The Board of Highbridge Multi-Strategy Fund Limited is delighted that Mr Paul Le Page has agreed to become a director of the Company. His extensive experience of risk management within the hedge fund sector equips him be a valuable addition to the Board".

 

There is no information concerning Mr Paul Le Page which is required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive and the Board consider him to be independent on appointment per the AIC Code of Corporate Governance. Mr Paul Le Page has no current or past relationship with either JP Morgan or Highbridge Capital Management, and is unrelated to the chairman of the Company's audit committee, Mr Steve Le Page.

 

As disclosed in the most recent Annual Financial Report, Mr Paul Meader is anticipating that he will retire from the Board in the final quarter of 2018.

 

For further information about this announcement contact:

JTC Fund Solutions (Guernsey) Limited

Secretary

Tel: +44 (0) 1481 702 400

 

E&OE - in transmission

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEUFESFASEIL
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.